Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 6 Nov 23 EFFECT Notice of effectiveness
- 30 Oct 23 F-3/A Shelf registration (foreign) (amended)
-
16 Oct 23 F-3 Shelf registration (foreign)
CMMB similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Chemomab Therapeutics Ltd.:
Chemomab Therapeutics Ltd.:
We consent to the use of our reports dated February 20, 2023 and March 30, 2022, with respect to the consolidated financial statements of Chemomab Therapeutics Ltd., incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ Somekh Chaikin |
Member Firm of KPMG International |
Tel Aviv, Israel
October 16, 2023